In what year did keytruda receive fda approval for cancer treatment?

Question

In what year did keytruda receive fda approval for cancer treatment?

Follow-up: In what year did Keytruda gain FDA approval for the first time? Can you name the specific cancer type Keytruda was approved for in its initial FDA approval? What was the year that Keytruda received additional FDA approval for treating other types of cancer?

Accepted Answer

Keytruda, a medication produced by Merck & Co., received its first approval from the U.S. Food and Drug Administration (FDA) for cancer treatment in 2014. This approval was specifically for the treatment of advanced melanoma, a type of skin cancer. [1]

Since its initial approval, Keytruda has received additional approvals from the FDA for the treatment of various other types of cancer. These include certain types of lung, head and neck, classical Hodgkin lymphoma, urothelial, microsatellite instability-high (MSI-H), and colorectal cancers. [1]

It is important to note that the specific approvals and indications for Keytruda can change over time, so it is always best to refer to the most recent information from the FDA or the drug's manufacturer for the most up-to-date details. [1]

### Sources:

* [1] DrugPatentWatch.com. Keytruda (pembrolizumab) Patent, BLA, and Approvals. <https://www.drugpatentwatch.com/drugs/keytruda>. Accessed on October 18, 2021.

Ask Anything...

Recent Questions

In what year did keytruda receive fda approval for cancer treatment?